E D Ehrenpreis

Summary

Publications

  1. ncbi request reprint A prospective, randomized, double-blind, placebo-controlled trial of retinol palmitate (vitamin A) for symptomatic chronic radiation proctopathy
    Eli D Ehrenpreis
    Gastroenterology and Radiation Oncology Divisions, University of Chicago Medical Center, Chicago, Illinois, USA
    Dis Colon Rectum 48:1-8. 2005
  2. pmc Hospitalizations for vaccine preventable pneumonias in patients with inflammatory bowel disease: a 6-year analysis of the Nationwide Inpatient Sample
    Derrick J Stobaugh
    Center for the Study of Complex Diseases, Research Institute, NorthShore University Healthsystem, Evanston, IL, USA Gastroenterology Department, NorthShore University Healthsystem, Highland Park, IL, USA
    Clin Exp Gastroenterol 6:43-9. 2013
  3. ncbi request reprint Infectious complications of TNF-α inhibitor monotherapy versus combination therapy with immunomodulators in inflammatory bowel disease: analysis of the Food and Drug Administration Adverse Event Reporting System
    Parakkal Deepak
    Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN USA Email
    J Gastrointestin Liver Dis 22:269-76. 2013
  4. doi request reprint The metoclopramide black box warning for tardive dyskinesia: effect on clinical practice, adverse event reporting, and prescription drug lawsuits
    Eli D Ehrenpreis
    Department of Gastroenterology, Evanston Hospital, NorthShore University Healthsystem, Evanston, Illinois 60201, USA
    Am J Gastroenterol 108:866-72. 2013
  5. doi request reprint Suboptimal reporting of adverse medical events to the FDA Adverse Events Reporting System by nurse practitioners and physician assistants
    Eli D Ehrenpreis
    NorthShore University Health System, Highland Park Hospital, 777 Park Avenue West, Highland Park, Illinois, USA
    Expert Opin Drug Saf 11:177-83. 2012
  6. ncbi request reprint Renal risks of sodium phosphate tablets for colonoscopy preparation: a review of adverse drug reactions reported to the US Food and Drug Administration
    E D Ehrenpreis
    Highland Park Hospital, NorthShore University Health System, and University of Chicago, Evanston, Illinois 60035, USA
    Colorectal Dis 13:e270-5. 2011
  7. pmc A dynamic model of once-daily 5-aminosalicylic acid predicts clinical efficacy
    Deepak Parakkal
    Highland Park Hospital, NorthShore University Health System and Clinical Associate Professor of Medicine, University of Chicago, 777 Park Avenue West, Highland Park, IL 60035, United States
    World J Gastroenterol 16:136-7. 2010
  8. doi request reprint Increased serum phosphate levels and calcium fluxes are seen in smaller individuals after a single dose of sodium phosphate colon cleansing solution: a pharmacokinetic analysis
    E D Ehrenpreis
    Department of Gastroenterology, Highland Park Hospital, NorthShore University Healthsystem, Highland Park, IL 60035, USA
    Aliment Pharmacol Ther 29:1202-11. 2009
  9. ncbi request reprint Pharmacotherapy for fecal incontinence: a review
    Eli D Ehrenpreis
    Division of Gastroenterology, Rush Medical Center, Chicago, Illinois, USA
    Dis Colon Rectum 50:641-9. 2007
  10. doi request reprint Neurological events with tumour necrosis factor alpha inhibitors reported to the Food and Drug Administration Adverse Event Reporting System
    P Deepak
    Department of Gastroenterology, Research Institute, NorthShore University Health System, Evanston, IL 60201, USA
    Aliment Pharmacol Ther 38:388-96. 2013

Collaborators

Detail Information

Publications24

  1. ncbi request reprint A prospective, randomized, double-blind, placebo-controlled trial of retinol palmitate (vitamin A) for symptomatic chronic radiation proctopathy
    Eli D Ehrenpreis
    Gastroenterology and Radiation Oncology Divisions, University of Chicago Medical Center, Chicago, Illinois, USA
    Dis Colon Rectum 48:1-8. 2005
    ..This study was designed to determine whether oral retinol palmitate (vitamin A) can reduce the symptoms of radiation proctopathy...
  2. pmc Hospitalizations for vaccine preventable pneumonias in patients with inflammatory bowel disease: a 6-year analysis of the Nationwide Inpatient Sample
    Derrick J Stobaugh
    Center for the Study of Complex Diseases, Research Institute, NorthShore University Healthsystem, Evanston, IL, USA Gastroenterology Department, NorthShore University Healthsystem, Highland Park, IL, USA
    Clin Exp Gastroenterol 6:43-9. 2013
    ....
  3. ncbi request reprint Infectious complications of TNF-α inhibitor monotherapy versus combination therapy with immunomodulators in inflammatory bowel disease: analysis of the Food and Drug Administration Adverse Event Reporting System
    Parakkal Deepak
    Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN USA Email
    J Gastrointestin Liver Dis 22:269-76. 2013
    ..Our aim was to analyze whether there is such an incremental increase in the odds of serious infections...
  4. doi request reprint The metoclopramide black box warning for tardive dyskinesia: effect on clinical practice, adverse event reporting, and prescription drug lawsuits
    Eli D Ehrenpreis
    Department of Gastroenterology, Evanston Hospital, NorthShore University Healthsystem, Evanston, Illinois 60201, USA
    Am J Gastroenterol 108:866-72. 2013
    ..We examined the effects of the black box warning about the risk of tardive dyskinesia (TD) with chronic use of metoclopramide on management of gastroparesis within a single clinical practice, and on reporting of adverse events...
  5. doi request reprint Suboptimal reporting of adverse medical events to the FDA Adverse Events Reporting System by nurse practitioners and physician assistants
    Eli D Ehrenpreis
    NorthShore University Health System, Highland Park Hospital, 777 Park Avenue West, Highland Park, Illinois, USA
    Expert Opin Drug Saf 11:177-83. 2012
    ..This study was performed to assess awareness and use of the AERS in voluntary reporting of drug toxicities by NPs and PAs...
  6. ncbi request reprint Renal risks of sodium phosphate tablets for colonoscopy preparation: a review of adverse drug reactions reported to the US Food and Drug Administration
    E D Ehrenpreis
    Highland Park Hospital, NorthShore University Health System, and University of Chicago, Evanston, Illinois 60035, USA
    Colorectal Dis 13:e270-5. 2011
    ..Although Fleet's Phospho-Soda has been removed from the US market, sodium phosphate tablets sold as OsmoPrep and Visicol remain available. Our aim was to analyse renal risks of the sodium phosphate tablets...
  7. pmc A dynamic model of once-daily 5-aminosalicylic acid predicts clinical efficacy
    Deepak Parakkal
    Highland Park Hospital, NorthShore University Health System and Clinical Associate Professor of Medicine, University of Chicago, 777 Park Avenue West, Highland Park, IL 60035, United States
    World J Gastroenterol 16:136-7. 2010
    ..In active colitis, sigmoid 5-ASA concentration becomes negligible. Our model supports once daily administration of Asacol as standard treatment for ulcerative colitis...
  8. doi request reprint Increased serum phosphate levels and calcium fluxes are seen in smaller individuals after a single dose of sodium phosphate colon cleansing solution: a pharmacokinetic analysis
    E D Ehrenpreis
    Department of Gastroenterology, Highland Park Hospital, NorthShore University Healthsystem, Highland Park, IL 60035, USA
    Aliment Pharmacol Ther 29:1202-11. 2009
    ..Sodium phosphate containing colonoscopy preparations may cause electrolyte disturbances and calcium-phosphate nephropathy. Decreased body weight is an unexplored risk factor for complications with sodium phosphate ingestion...
  9. ncbi request reprint Pharmacotherapy for fecal incontinence: a review
    Eli D Ehrenpreis
    Division of Gastroenterology, Rush Medical Center, Chicago, Illinois, USA
    Dis Colon Rectum 50:641-9. 2007
    ..A new classification to easily remember the treatment categories for this condition, based on the "ABCs of treatment for fecal incontinence," has been introduced into the structure of this review...
  10. doi request reprint Neurological events with tumour necrosis factor alpha inhibitors reported to the Food and Drug Administration Adverse Event Reporting System
    P Deepak
    Department of Gastroenterology, Research Institute, NorthShore University Health System, Evanston, IL 60201, USA
    Aliment Pharmacol Ther 38:388-96. 2013
    ..The association between inhibition of tumour necrosis factor alpha (TNF-α) and new onset of neurological adverse events (AEs) is unclear...
  11. ncbi request reprint Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial
    E D Ehrenpreis
    Department of Gastroenterology, University of Chicago Hospitals, Chicago, IL 60637, USA
    Gastroenterology 117:1271-7. 1999
    ..Inhibition of tumor necrosis factor is a proposed mechanism for the anti-inflammatory properties of thalidomide. We performed an open-label trial of thalidomide in refractory Crohn's disease...
  12. ncbi request reprint Treatment of anal fissures with topical nitroglycerin
    E D Ehrenpreis
    Department of Gastroenterology, University of Chicago Hospitals, 5841 South Maryland Avenue, MC 4076, Chicago, Illinois 60637, USA
    Expert Opin Pharmacother 2:41-5. 2001
    ..This review summarises current literature regarding topical nitroglycerin pharmacotherapy for anal fissure...
  13. ncbi request reprint Thalidomide treatment for refractory Crohn's disease: a review of the history, pharmacological mechanisms and clinical literature
    P M Ginsburg
    Department of Gastroenterology, University of Chicago Hospitals, IL 60637, USA
    Ann Med 33:516-25. 2001
    ..Special attention is directed towards its history, mechanisms, and proposed role. The recent development of thalidomide analogues is also discussed briefly...
  14. doi request reprint Increased risk of osteoporosis-related fractures in patients with irritable bowel syndrome
    D J Stobaugh
    Center for the Study of Complex Diseases, Research Institute, Department of Gastroenterology, NorthShore University Health System, 1001 University Place, Evanston, IL 60201, USA
    Osteoporos Int 24:1169-75. 2013
    ..Screening measures to identify osteoporosis in this group are advised...
  15. ncbi request reprint Review article: current therapeutic options for radiation proctopathy
    J J Hong
    Gastroenterology Division, Department of Medicine, University of Chicago, Pritzker School of Medicine, Chicago, IL 60637, USA
    Aliment Pharmacol Ther 15:1253-62. 2001
    ..Given that formal randomized placebo-controlled studies are lacking for most treatments, the management of these patients is often challenging and unclear. Hence, there is a need for more research and education on radiation proctopathy...
  16. doi request reprint A dynamic model of colonic concentrations of delayed-release 5-aminosalicylic acid (Asacol)
    M P Thorpe
    Division of Nutritional Sciences, University of Illinois, Urbana, IL, USA
    Aliment Pharmacol Ther 29:1193-201. 2009
    ..5-ASA in a pH sensitive tablet (Asacol) is administered as three doses/day to treat ulcerative colitis. Once daily dosing may improve patient adherence. Simulation of colonic levels of 5-ASA can be used to compare dosing regimens...
  17. ncbi request reprint Retrograde endoscopic delivery of botulinum toxin for anal fissures
    T P Kinney
    University of Chicago Medical Center, Chicago, Illinois 60637, USA
    Endoscopy 38:654. 2006
  18. ncbi request reprint Improving the serum D-xylose test for the identification of patients with small intestinal malabsorption
    E D Ehrenpreis
    Division of Gastroenterology, Department of Medicine, University of Chicago Hospitals, 5841 South Maryland Avenue, Chicago, IL 60637
    J Clin Gastroenterol 33:36-40. 2001
    ..CONCLUSIONS: Thus, the addition of a 3-hour D-xylose serum level of less than 22.5 mg/dL to conventional 1-hour D-xylose determination greatly improves the D-xylose test for malabsorption screening...
  19. ncbi request reprint A pilot study of thalidomide for patients with symptomatic mesenteric panniculitis
    P M Ginsburg
    Division of Gastroenterology, Department of Medicine, University of Chicago Hospitals, Chicago, IL 60637, USA
    Aliment Pharmacol Ther 16:2115-22. 2002
    ..Mesenteric panniculitis is a rare condition with no standard therapy...
  20. ncbi request reprint Gastro-oesophageal reflux disease in obesity: pathophysiological and therapeutic considerations
    N Barak
    Department of Medicine, Section of Gastroenterology Nutrition, University of Chicago Hospitals, Chiacgo, Illinois, USA
    Obes Rev 3:9-15. 2002
    ..This review outlines the pathophysiology and the treatment of GERD in obesity with emphasis on the therapeutic considerations in this population of patients...
  21. ncbi request reprint Oral vitamin a therapy for a patient with a severely symptomatic postradiation anal ulceration: report of a case
    Josh Levitsky
    Section of Gastroenterology, Department of Medicine, University of Chicago Hospitals, Chicago, Illinois, USA
    Dis Colon Rectum 46:679-82. 2003
    ..Vitamin A seems to be very effective in the treatment of radiation-induced anorectal damage, with little toxicity and expense...
  22. ncbi request reprint Alvimopan (Adolor/GlaxoSmithKline)
    Ijeoma A Azodo
    University of Chicago, Department of Medicine, IL 60637, USA
    Curr Opin Investig Drugs 3:1496-501. 2002
    ..Alvimopan is a potent, peripherally active, mu-opioid receptor antagonist being developed by Adolor and GlaxoSmithKline (GSK) as a potential treatment for post-operative ileus and opioid bowel dysfunction...
  23. ncbi request reprint Accuracy and reliability of the endoscopic classification of chronic radiation-induced proctopathy using a novel grading method
    Kenneth D Chi
    Department of Medicine, Section of Gastroenterology, University of Chicago, Chicago, IL 60637, USA
    J Clin Gastroenterol 39:42-6. 2005
    ..To assess a novel grading method of radiation proctitis for intraobserver and interobserver agreement among endoscopists...